Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell-led drug repurposing for Alzheimer’s disease
Silvia Parolo, Federica Mariotti, Pranami Bora, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Drug Repurposing using Artificial Intelligence, Molecular Docking, and Hybrid Approaches: A Comprehensive Review in General Diseases vs Alzheimer's Disease
Natasha Azeelen Zulhafiz, Teoh Teik Toe, Ai‐Vyrn Chin, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 261, pp. 108604-108604
Closed Access | Times Cited: 1
Drug repurposing: a nexus of innovation, science, and potential
Maria Cristina De Rosa, Rituraj Purohit, Alfonso T. García‐Sosa
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions
Soumilee Chaudhuri, Minyoung Cho, Julia C. Stumpff, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Integrating GWAS and Transcriptome Data through PrediXcan and Multimodal Deep Learning to Reveal Genetic Basis and Novel Drug Repositioning Opportunities for Alzheimer's Disease
Xuecong Tian, Ying Su, Sizhe Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
Shraddha M. Dalwadi, Andrew Hunt, Mark Bonnen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases
Lijuan Shu, Chunfu Du, Yunxia Zuo
Journal of Neuropathology & Experimental Neurology (2023) Vol. 82, Iss. 10, pp. 826-835
Closed Access | Times Cited: 7
Cerebrovascular miRNAs Track Early Development of Alzheimer’s Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation
Phoebe P. Chum, Mary A. Bishara, Summer R. Solis, et al.
Journal of Alzheimer s Disease (2023) Vol. 99, Iss. s2, pp. S187-S234
Open Access | Times Cited: 5
Approaching fuzzy sliding mode strategy for automotive suspension based on the view of enhancing ride comfort and vehicle stability
Tuan Anh Nguyen
Measurement and Control (2024)
Open Access | Times Cited: 1
Atomoxetine suppresses radioresistance in glioblastoma via circATIC/miR-520d-5p/Notch2-Hey1 axis
Hyun Jeong Seok, Jae Yeon Choi, Dong Hyeon Lee, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Caterina Carraro, Jessica V. Montgomery, Julien Klimmt, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Recent Advances and Challenges in Targeted Drug Delivery Using Biofunctional Coatings
Tuğba Bal, Nasma Anjrini, Meryem Zeroual
Royal Society of Chemistry eBooks (2024), pp. 41-75
Closed Access
Data-driven discovery of cell-type-directed network-correcting combination therapy for Alzheimer's disease
Yaqiao Li, Carlota Pereda Serras, Jessica Blumenfeld, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer’s Disease Patients
M. Oosthoek, An L, António Almeida, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top